SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-047707
Filing Date
2018-07-27
Accepted
2018-07-27 16:04:34
Documents
2
Period of Report
2018-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-17784_38k.htm 8-K 23063
2 EX-10.1 a18-17784_3ex10d1.htm EX-10.1 210519
  Complete submission text file 0001104659-18-047707.txt   234716
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 18974877
SIC: 2834 Pharmaceutical Preparations